MotherToBaby

Medications and More during pregnancy and breastfeeding

Search

866.626.6847

Hydrocodone

Selected References

  • Anderson PO et al, 2007 Hydrocodone excretion into breast milk: the first two reported cases. Breastfeeding Medicine 2(1):10-14.
  • Azuine RE et al, 2019. Prenatal risk factors and perinatal and postnatal outcomes associated with maternal opioid exposure in an urban, low-income, multiethnic US population. JAMA network open, 2(6); e196405-196405.
  • Broussard CS et al, 2011. Maternal treatment with opioid analgesics and risk for birth defects. Am J Obstet Gynecol 204(4):314.e1-11.
  • Desai RJ et al, 2015. Exposure to prescription opioid analgesics in utero and risk of neonatal abstinence syndrome: population based cohort study. BMJ 350:h2012.
  • Fishman B et al, 2019. Pregnancy outcome following opioid exposure: A cohort study. PloS one, 14(7).
  • Fronczak CM et al, 2012. The insults of illicit drug use on male fertility. Journal of andrology, 33(4): 515-528.
  • Heinonen OP et al, 1977. Birth Defects and Drugs in Pregnancy. Littleton, MA: Publishing Sciences Group.
  • Hsieh A, 2018. Management Strategies in Opioid Abuse and Sexual Dysfunction: A Review of Opioid-Induced Androgen Deficiency. Sexual medicine reviews, 6(4): 618-623.
  • Kellogg A et al, 2011. Current trends in narcotic use in pregnancy and neonatal outcomes. Am J Obstet Gynecol 204(3):259.e1-4.
  • Lind JN et al, 2017. Maternal use of opioids during pregnancy and congenital malformations: a systematic review. Pediatrics, 139(6), e20164131.
  • Patrick SW et al, 2015. Prescription opioid epidemic and infant outcomes. Pediatrics 135(5):842-850.
  • Reece-Stremtan S et al, 2017. ABM Clinical Protocol #15: Analgesia and Anesthesia for the Breastfeeding Mother, Revised 2017. Breastfeeding Medicine 12(9).
  • Rosa F, personal communication, FDA, 1993. Cited in: Briggs GG et al. Drugs in Pregnancy and Lactation Online, Hudson, Ohio: Wolters Kluwer Clinical Drug Information, Inc. Nov 15, 2017.
  • Sauberan JB et al, 2011. Breast milk hydrocodone and hydromorphone levels in mothers using hydrocodone for postpartum pain. Obst Gynecol 117(3):611-617.
  • Schick B et al, 1996. Preliminary analysis of first trimester exposure to oxycodone and hydrocodone. Reprod Toxicol 10:162.
  • Semet M et al, 2017. The impact of drugs on male fertility: a review. Andrology, 5(4), 640-663.
  • Shirel T et al, 2016. Maternal opioid dose is associated with neonatal abstinence syndrome in children born to women with sickle cell disease. Am J Hematology 91(4):416-416.
  • Smith MV et al, 2015. Clinical correlates of prescription opioid analgesic use in pregnancy. Matern Child Health J 19(3):548-556.
  • Sujan AC et al, 2019. Maternal prescribed opioid analgesic use during pregnancy and associations with adverse birth outcomes: A population-based study. PLoS Medicine, 16(12).

This website is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $6,000,000 with zero percentage financed with non-governmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, HRSA, HHS, or the U.S. Government.